NASDAQ:RCKT

Rocket Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy RCKT

*Your capital is at risk

$2.92

+0.0300 (+1.04%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

RCKT Prediction Chart

RCKT Predictions History

Latest community submissions for RCKT.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Aug 26, 2022	$18.65 +1.30%	$16.21	X	84.95%	0
gertschepens.338211	Aug 26, 2022	$21.00 +14.07%	$16.21	X	70.45%	0
JS Pro	Aug 22, 2022	$16.46 -2.31%	$16.41	V	99.70%	5
gertschepens.338211	Aug 22, 2022	Bullish	$16.41	X	—	0
JS Pro	Aug 18, 2022	$17.33 -1.76%	$17.34	V	99.94%	10
gertschepens.338211	Aug 18, 2022	Bullish	$17.34	X	—	0
JS Pro	Aug 15, 2022	$17.81 +1.95%	$18.32	V	97.22%	1
emilythewelder	Aug 15, 2022	Bullish	$18.32	V	—	1
gertschepens.338211	Aug 15, 2022	Bearish	$18.32	X	—	0
gertschepens.338211	Aug 15, 2022	$13.58 -17.35%	$18.32	X	74.13%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for RCKT with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ROCKET PHARMACEUTICALS INC

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by